Hadley Harbor Master Investors (Cayman) L.P.
CIK 1641080 · last filed 2020-03-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$350.53M
Companies
16
Total Filings
29
Lifetime Open-Market Net
-$187.69M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTON | 10%+ Owner | 5,238,878 | $5.55 | $29.08M | -$126.91M | 5 | 2020-03-26 |
| PINS | 10%+ Owner | — | $20.21 | — | $0 | 1 | 2019-04-23 |
| Neon Therapeutics, Inc. (NTGN) Delisted | 10%+ Owner | 665,922 | — | — | $0 | 1 | 2018-06-29 |
| LASR | 10%+ Owner | 3,339,734 | $69.66 | $232.65M | $0 | 1 | 2018-04-30 |
| ZUORA INC (ZUO) Delisted | 10%+ Owner | — | $10.02 | — | $0 | 1 | 2018-04-16 |
| Allena Pharmaceuticals, Inc. (ALNA) Delisted | 10%+ Owner | 757,684 | $0.07 | $56.8K | $0 | 1 | 2017-11-07 |
| FORESCOUT TECHNOLOGIES, INC (FSCT) Delisted | 10%+ Owner | 1,978,749 | — | — | $0 | 1 | 2017-10-31 |
| RYTM | 10%+ Owner | 545,256 | $88.38 | $48.19M | $0 | 1 | 2017-10-10 |
| KALA | 10%+ Owner | 888,894 | $2.63 | $2.34M | $0 | 1 | 2017-07-25 |
| TTD | 10%+ Owner | 1,782,907 | $19.28 | $34.37M | -$60.77M | 10 | 2017-05-01 |
| Jounce Therapeutics, Inc. (JNCE) Delisted | 10%+ Owner | 719,476 | $1.88 | $1.35M | $0 | 1 | 2017-02-01 |
| CRISPR Therapeutics AG (PZRX) Delisted | 10%+ Owner | 744,380 | — | — | $0 | 1 | 2016-10-24 |
| VYGR | 10%+ Owner | 470,588 | $3.50 | $1.65M | $0 | 1 | 2015-11-18 |
| CTMX | 10%+ Owner | 749,055 | $3.01 | $2.25M | $0 | 1 | 2015-10-14 |
| ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | 10%+ Owner | 364,358 | — | — | $0 | 1 | 2015-06-23 |
| Invuity, Inc. (IVTY) Delisted | 10%+ Owner | 948,803 | — | — | $0 | 1 | 2015-06-22 |
Recent Filings · Page 3 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-30 | TTD | Sell (S) | −161,400 | -$6.05M | EDGAR |
| 2017-03-28 | TTD | Sell (S) | — | $0 | EDGAR |
| 2017-02-01 | Jounce Therapeutics, Inc. (JNCE) Delisted | Conv (C) | +719,476 | $0 | EDGAR |
| 2016-10-24 | CRISPR Therapeutics AG (PZRX) Delisted | Conv (C) | +744,380 | $0 | EDGAR |
| 2016-09-26 | TTD | Conv (C) | — | $0 | EDGAR |
| 2015-11-18 | VYGR | Conv (C) | +470,588 | $0 | EDGAR |
| 2015-10-14 | CTMX | Conv (C) | +749,055 | $0 | EDGAR |
| 2015-06-23 | ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Conv (C) | +364,358 | $0 | EDGAR |
| 2015-06-22 | Invuity, Inc. (IVTY) Delisted | Conv (C) | +948,803 | $0 | EDGAR |
Showing 21–29 of 29
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.